WAKAMOTO PHARMACEUTICAL CO.,LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 226 JPY | -1.74% |
|
-3.00% | +6.10% |
| Sales 2011 | 9.67B 61.04M 5.09B | Sales 2012 | 9.43B 59.54M 4.97B | Capitalization | 8.59B 54.26M 4.53B |
|---|---|---|---|---|---|
| Net income 2011 | -425M -2.68M -224M | Net income 2012 | -222M -1.4M -117M | EV / Sales 2011 | 0.9 x |
| Net cash position 2011 | 156M 985K 82.14M | Net cash position 2012 | 212M 1.34M 112M | EV / Sales 2012 | 0.89 x |
| P/E ratio 2011 |
-20.8
x | P/E ratio 2012 |
-38.7
x | Employees | 403 |
| Yield 2011 * |
-
| Yield 2012 |
-
| Free-Float | 63.42% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.74% | ||
| 1 week | -3.00% | ||
| Current month | -0.44% | ||
| 1 month | -0.44% | ||
| 3 months | +6.10% | ||
| 6 months | +10.24% | ||
| Current year | +6.10% |
1 week
226.00
234.00
1 month
222.00243.00
Current year
197.00252.00
1 year
189.00261.00
3 years
189.00410.00
5 years
188.00754.00
10 years
188.00754.00
| Managers | Title | Age | Since |
|---|---|---|---|
Arata Igarashi
PSD | President | 65 | 01/10/01 |
Kimihiko Sato
BRD | Director/Board Member | 58 | 01/88/01 |
Haruhisa Hirata
BRD | Director/Board Member | 67 | 01/79/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Katsuyoshi Ejima
BRD | Director/Board Member | 70 | 01/16/01 |
Haruhisa Hirata
BRD | Director/Board Member | 67 | 01/79/01 |
Arata Igarashi
PSD | President | 65 | 01/10/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 15 M€ | +7.34% | ||
| 0.00% | 18 M€ | +16.15% | - | |
| 0.00% | 144,586 M€ | +14.49% | ||
| 0.00% | 66,066 M€ | +14.68% | - | |
| 0.00% | 20,721 M€ | +13.52% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 226 | -1.74% | 239,900 |
| 25/24/25 | 230 | -1.29% | 46,800 |
| 24/24/24 | 233 | +0.87% | 42,300 |
| 23/24/23 | 231 | -0.43% | 29,200 |
| 22/24/22 | 232 | -0.43% | 39,200 |
Delayed Quote Japan Exchange, April 26, 2024 at 11:30 am IST
More quotes
WAKAMOTO PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the manufacture and sale of ethical drugs such as gastrointestinal drugs and non-prescription drugs. The Company operates through four business segments. The Pharmaceuticals segment is involved in the manufacture and sale of innovator drugs, generic drugs and optiaid series supplements mainly in the ophthalmic field, as well as the commission of production and the sale of diagnostic drugs and raw materials in Japan. The Healthcare segment sales its core product Kawakami Wakamoto, the Avantbise series of medicated toothpastes that promote bad breath prevention based on evidence and Avantbise Oral Tablet mainly in the mail order business. The International segment is involved in the business related to the export of products and raw materials mainly in Asia and Europe, as well as the new license in and out business. The Real Estate Leasing segment is involved in the rental business of Coredo Muromachi.
Sector
Pharmaceuticals
Calendar
15/05/2024
- Q4 2023 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +6.10% | 49.95M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 4512 Stock
